Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REST trial in children with acute otitis media with discharge
2017-003635-10Phase 4Completed
- Sponsor
- University of Bristol
- Start
- May 2018
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ciprofloxacin, amoxicillin and clarithromycin in acute otitis media (AOM) (3 arms), sponsored by University of Bristol. Primary endpoint: Time to resolution. Started May 2018; status: completed.
02
Drugs
ciprofloxacinamoxicillinclarithromycin
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on 2017-003635-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003635-10.